Analyzing characteristics of BPPV patients in China
Cohort Study of Clinical and Neuroimaging Characteristics for BPPV Patients in China
First Affiliated Hospital Xi'an Jiaotong University · NCT06228196
This study is trying to understand the characteristics of people with BPPV in China by looking at their brain scans, blood tests, and mental health to help improve diagnosis and treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 150 (estimated) |
| Ages | 18 Years to 60 Years |
| Sex | All |
| Sponsor | First Affiliated Hospital Xi'an Jiaotong University (other) |
| Locations | 1 site (Xi'an, Shaanxi) |
| Trial ID | NCT06228196 on ClinicalTrials.gov |
What this trial studies
This observational study aims to analyze the clinical and neuroimaging characteristics of patients diagnosed with benign paroxysmal positional vertigo (BPPV) in China. Participants will undergo psychological assessments, blood tests, and multiple brain MRI scans over a period of six months to explore the biological mechanisms and identify predictive biomarkers associated with BPPV. The study also seeks to establish a comprehensive database that can aid in the precise diagnosis and management of BPPV and its residual dizziness. Healthy controls will be included for comparative analysis.
Who should consider this trial
Good fit: Ideal candidates include individuals diagnosed with BPPV and healthy subjects without a history of the condition.
Not a fit: Patients with a history of central nervous system diseases or mental disorders, as well as those who are claustrophobic, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnosis and management strategies for patients suffering from BPPV and residual dizziness.
How similar studies have performed: While similar studies have explored BPPV, this specific approach combining neuroimaging and psychological assessments is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Confirmed diagnosis of BPPV/Healthy subjects who have not had BPPV Exclusion Criteria: * History of organic diseases in central nervous system and mental disorder, such as tumors, infections, depressive disorder, schizophrenia, etc. Claustrophobic
Where this trial is running
Xi'an, Shaanxi
- The First Affiliated Hospital of Xi'an Jiaotong University — Xi'an, Shaanxi, China (RECRUITING)
Study contacts
- Principal investigator: Yuan Wang, M.D. — First Affiliated Hospital of Xian Jiaotong University
- Study coordinator: Yuan Wang, M.D.
- Email: wangyuan8003@126.com
- Phone: 0086-13324598144
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: BPPV, Vertigo, Vertigo, Peripheral, residual dizziness, Neuroimaging, Epidemic